VOGX SCHEDULE 13G: SEC filing
OrbiMed Advisors LLC and OrbiMed Capital LLC
Filed with the SEC on · accession 0000947871-26-001036
VOGX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
OrbiMed Advisors LLC and OrbiMed Capital LLC filed a Schedule 13G disclosing passive ownership of Vogenx, Inc. common stock, with OrbiMed Advisors holding 647,633 shares (4.4%) and OrbiMed Capital holding 320,988 shares (2.2%), for a combined 6.5% stake.
Key details
✦ Ask GOAX AI about this filing — what it means for VOGX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VOGX?
Click hereFrequently asked questions
What did VOGX file with the SEC on Nov 16, 2026?
VOGX filed a SCHEDULE 13G (SEC filing). OrbiMed Advisors LLC and OrbiMed Capital LLC filed a Schedule 13G disclosing passive ownership of Vogenx, Inc. common stock, with OrbiMed Advisors holding 647,633 shares (4.4%) and OrbiMed Capital holding 320,988 shares (2.2%), for a combined 6.5% stake.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
Other VOGX SEC filings
Get alerts when VOGX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days